Cigna Group (NYSE:CI) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Cigna Group (NYSE:CI) has earned a consensus rating of “Moderate Buy” from the twenty-two ratings firms that are covering the stock, MarketBeat reports. Six equities research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $338.80.

A number of equities research analysts have recently weighed in on CI shares. Sanford C. Bernstein lifted their price objective on Cigna Group from $371.00 to $381.00 and gave the company an “outperform” rating in a research note on Thursday, July 9th. Mizuho raised their target price on Cigna Group from $330.00 to $340.00 and gave the company an “outperform” rating in a report on Monday, June 8th. The Goldman Sachs Group boosted their price target on shares of Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. Morgan Stanley increased their price target on shares of Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 20th. Finally, Wall Street Zen raised shares of Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, June 20th.

Cigna Group Stock Performance

Shares of CI stock opened at $283.06 on Friday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. The firm has a market cap of $74.88 billion, a P/E ratio of 12.00, a P/E/G ratio of 1.15 and a beta of 0.29. The firm’s 50 day moving average price is $286.81 and its 200-day moving average price is $280.39. Cigna Group has a one year low of $239.51 and a one year high of $315.47.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, beating the consensus estimate of $7.60 by $0.19. The firm had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter last year, the firm earned $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, equities research analysts predict that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th were given a $1.56 dividend. This represents a $6.24 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend was Thursday, June 4th. Cigna Group’s dividend payout ratio (DPR) is currently 26.45%.

Insider Buying and Selling at Cigna Group

In related news, CEO David Cordani sold 201,878 shares of Cigna Group stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the transaction, the chief executive officer directly owned 34,337 shares in the company, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 0.60% of the company’s stock.

Hedge Funds Weigh In On Cigna Group

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Tema ETFs LLC grew its position in shares of Cigna Group by 10.5% during the second quarter. Tema ETFs LLC now owns 4,566 shares of the health services provider’s stock worth $1,259,000 after buying an additional 435 shares in the last quarter. Handelsbanken Fonder AB lifted its stake in Cigna Group by 12.1% in the second quarter. Handelsbanken Fonder AB now owns 82,825 shares of the health services provider’s stock worth $22,833,000 after acquiring an additional 8,960 shares during the last quarter. Community Financial Services Group LLC acquired a new position in Cigna Group during the 2nd quarter worth approximately $50,000. Everhart Financial Group Inc. increased its position in shares of Cigna Group by 3.4% in the 2nd quarter. Everhart Financial Group Inc. now owns 3,641 shares of the health services provider’s stock valued at $1,004,000 after purchasing an additional 121 shares during the last quarter. Finally, Everpar Advisors LLC acquired a new stake in shares of Cigna Group in the 2nd quarter valued at $201,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.